Alexion Pharmaceuticals organizacji Kapitalizacja rynkowa
Jaka jest wartość Kapitalizacja rynkowa organizacji Alexion Pharmaceuticals?
Wartość Kapitalizacja rynkowa organizacji Alexion Pharmaceuticals Inc. to $40.34B
Jaka jest definicja Kapitalizacja rynkowa?
Kapitalizacja rynkowa (Market cap) jest wartością rynkową wyemitowanych akcji spółki giełdowej i jest równa cenie akcji w tym czasie pomnożonej przez liczbę wyemitowanych akcji .
As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.
Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.
The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.
Kapitalizacja rynkowa firm w Health Care sektor na NASDAQ w porównaniu do Alexion Pharmaceuticals
Czym się zajmuję organizacja Alexion Pharmaceuticals?
Alexion is a global biopharmaceutical company focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development and commercialization of life-changing medicines. As a leader in rare diseases for more than 25 years, Alexion has developed and commercializes two approved complement inhibitors to treat patients with paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS), as well as the first and only approved complement inhibitor to treat anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG) and neuromyelitis optica spectrum disorder (NMOSD). Alexion also has two highly innovative enzyme replacement therapies for patients with life-threatening and ultra-rare metabolic disorders, hypophosphatasia (HPP) and lysosomal acid lipase deficiency (LAL-D) as well as the first and only approved Factor Xa inhibitor reversal agent. In addition, the company is developing several mid-to-late-stage therapies, including a copper-binding agent for Wilson disease, an anti-neonatal Fc receptor (FcRn) antibody for rare Immunoglobulin G (IgG)-mediated diseases and an oral Factor D inhibitor as well as several early-stage therapies, including one for light chain (AL) amyloidosis, a second oral Factor D inhibitor and a third complement inhibitor. Alexion focuses its research efforts on novel molecules and targets in the complement cascade and its development efforts on hematology, nephrology, neurology, metabolic disorders, cardiology, ophthalmology and acute care. Headquartered in Boston, Massachusetts, Alexion has offices around the globe and serves patients in more than 50 countries.
Firmy z kapitalizacja rynkowa podobne do Alexion Pharmaceuticals
- Wartość Kapitalizacja rynkowa organizacji Biogen to $40.10B
- Wartość Kapitalizacja rynkowa organizacji Baidu Inc to $40.15B
- Wartość Kapitalizacja rynkowa organizacji Ross Stores to $40.17B
- Wartość Kapitalizacja rynkowa organizacji Sysco to $40.20B
- Wartość Kapitalizacja rynkowa organizacji Chipotle Mexican Grill to $40.27B
- Wartość Kapitalizacja rynkowa organizacji Atwood Oceanics to $40.28B
- Wartość Kapitalizacja rynkowa organizacji Alexion Pharmaceuticals to $40.34B
- Wartość Kapitalizacja rynkowa organizacji Microchip Technology to $40.34B
- Wartość Kapitalizacja rynkowa organizacji Ferrari N.V to $40.35B
- Wartość Kapitalizacja rynkowa organizacji HP to $40.36B
- Wartość Kapitalizacja rynkowa organizacji Lululemon Athletica to $40.37B
- Wartość Kapitalizacja rynkowa organizacji BCE Inc to $40.38B
- Wartość Kapitalizacja rynkowa organizacji Sysco to $40.42B